Oruka Therapeutics Inc (ORKA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0.005% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
93 |
$334,848,002 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Viking Global Investors |
0.41 |
Reduce 43.62% |
1,503,478 |
143,086,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 27 Feb 2025 |
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. |
10% |
14 Feb 2025 |
88,794 |
11.44 |
1,015,803 |
| 27 Feb 2025 |
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. |
10% |
13 Feb 2025 |
14,950 |
11.63 |
173,868 |
| 27 Feb 2025 |
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. |
10% |
12 Feb 2025 |
8,971 |
11.86 |
106,396 |
| 27 Feb 2025 |
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. |
10% |
11 Feb 2025 |
9,593 |
10.95 |
105,043 |
| 27 Feb 2025 |
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. |
10% |
10 Feb 2025 |
574 |
10.90 |
6,257 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock